Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Auransa Inc.”

4 pharma patents match "Auransa Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Auransa Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Auransa Inc.” · 30,257 patents in full index Clear search

  1. US 11786503

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  2. US 11166936

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  3. US 10874633

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  4. US 10806716

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.